Segmentation for Classification of Screening Pancreatic Neuroendocrine
  Tumors by Zhu, Zhuotun et al.
Segmentation for Classification of Screening
Pancreatic Neuroendocrine Tumors
Zhuotun Zhu1, Yongyi Lu1,
Wei Shen1, Elliot K. Fishman2, Alan L. Yuille1
1The Johns Hopkins University, Baltimore, MD 21218, USA
{zhuotun,yylu1989,shenwei1231,alan.l.yuille}@gmail.com
2The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
efishman@jhmi.edu
Abstract. This work presents comprehensive results to detect in the
early stage the pancreatic neuroendocrine tumors (PNETs), a group of
endocrine tumors arising in the pancreas, which are the second common
type of pancreatic cancer, by checking the abdominal CT scans. To the
best of our knowledge, this task has not been studied before as a com-
putational task. To provide radiologists with tumor locations, we adopt
a segmentation framework to classify CT volumes by checking if at least
a sufficient number of voxels is segmented as tumors. To quantitatively
analyze our method, we collect and voxelwisely label a new abdominal
CT dataset containing 376 cases with both arterial and venous phases
available for each case, in which 228 cases were diagnosed with PNETs
while the remaining 148 cases are normal, which is currently the largest
dataset for PNETs to the best of our knowledge. In order to incorpo-
rate rich knowledge of radiologists to our framework, we annotate dilated
pancreatic duct as well, which is regarded as the sign of high risk for pan-
creatic cancer. Quantitatively, our approach outperforms state-of-the-art
segmentation networks and achieves a sensitivity of 89.47% at a speci-
ficity of 81.08%, which indicates a potential direction to achieve a clinical
impact related to cancer diagnosis by earlier tumor detection.
Keywords: Pancreatic Neuroendocrine Tumors (PNETs), CT Scan.
1 Introduction
The American Cancer Society estimates that about 56,770 people in the United
States will be diagnosed with pancreatic cancer in 2019, and that 45,750 will
die from the disease [10]. The oncology community has expended arsenal at this
disease with little effect: the 5-year survival rate remains at only ≈ 5% [11] de-
spite decades of effort. This is due to the fact that most patients with localized
disease have no recognizable symptoms or signs; as a result, upon diagnosis,
tumors have generally spread to critical abdominal vessels and/or adjacent or-
gans, which is too late to be cured. Despite the grim statistics, there is still real
hope for the early detection, which can boost the 5-year survival rate by 3 times
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to reach around 20% given an early diagnosis [7]. Among pancreatic cancers,
the pancreatic adenocarcinoma (PDAC) is the most common type of pancreatic
cancer. Recently, there is a study [15] showing that they can achieve an overall
sensitivity of 94.1% at a specificity of 98.5% for the detection of PDAC, which
sheds light on the possibility of early pancreatic cancer detection. In our work,
we focus on the early detection of pancreatic neuroendocrine tumors (PNETs)
from CT scans, which is harder than the detection of PDAC considering PNETs
are less common with even smaller voxel size.
The detection of PNETs falls into the area of computer aided diagnosis. The
main challenges are lying in three folds: 1) the small size of tumors with respect
to the whole volume; 2) the large tumor variations in location, shape and size
across different patients; 3) the abnormalities can change the texture of sur-
rounding tissues a lot, which makes the task even harder to locate the tumor
targets. With the unprecedented development of deep learning, in particularly
fully convolutional neural networks (FCNs), there are works which has been
driving the field forward in image segmentation [2,6,8]. In the pancreas segmen-
tation area, researchers have been actively pushing the boundaries of obtaining
accurate segmentation performance on both normal pancreas [1,9] and abnormal
pancreas [13,14].
Valuable insights from radiologists’ clinical diagnosis and analysis process can
be leveraged to tackle this problem. First, radiologists are very sensitive to the
dilated pancreatic duct when reading CT scans. There are often occasions the
pancreatic duct is visible to be dilated though the PNETs are barely visible from
CT appearance and texture, in which case the PNETs are correctly imagined to
be at the cut-off region of the dilated pancreatic duct. Second, the appearance
and texture cues can be very different for PNETs between the venous and arte-
rial phases of CT scans. Radiologists make diagnosis decision by checking both
phases in case the PNETs are hardly to be picked up in one phase. Missing true
PNETs can cause critical areas to remain untreated. To migrate the aforemen-
tioned practical knowledge from radiologists routine works to our system, on the
one hand, we annotated the voxels of dilated pancreatic duct as strong auxiliary
cues to indicate the present of pancreatic cancer. On the other hand, we conduct
PNETs segmentation and classification on both arterial and venous phases to
reduce the missing detection of PNETs. This is done quite different from the
state-of-the-art work on PDACs [15], where they only study on one phase and
no cues are explored from the dilated pancreatic duct. Our final goal is aimed to
detect PNETs from a mixed set of normal and abnormal CT scans. It is not a
simple binary classification task because radiologists want to know the location
of tumors, so we use the idea of Segmentation-for-Classification (S4C), which
trains segmentation models and uses voxel predictions for the classification.
Our contributions are three folds: 1) we voxelwisely label a dual-phase
PNETs dataset in both arterial and venous phases, which is the largest dataset
and study up-to-date to the best of our knowledge; 2) we are the first work of
segmentation and classification for PNETs, where the segmentation makes the
classification task interpretable and extra cues from the dilated pancreatic duct
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are incorporated in proposed framework; 3) our overall framework achieves a
sensitivity of 89.47% at a specificity of 81.08%, which indicates the potential
direction to a clinical impact.
2 Method
2.1 The Overall Framework
We denote the dataset as D = {(X1, y1) , . . . , (XN , yN )}, where N is total num-
ber of CT cases, Xn ∈ RWn×Hn×Ln is a 3D volume with each voxel defined as
the Hounsfield Unit (HU), and yn ∈ {0, 1} is the case label, by which 0 means a
normal case while 1 for an abnormal case. By abnormal/tumor we mean cases
diagnosed with PNETs throughout the whole paper. Our goal is to design a
model M : y = f(X) mapping a CT image to its state of being abnormal or not.
Some previous work suggested to classify medical images by directly using
deep neural networks [4,5], however, we claim that a better strategy is to per-
form tumor segmentation together with the classification task. This makes the
prediction interpretable for the classification results from segmentation cues,
by which radiologists can take a further investigation of the suspicious abnor-
mal regions. But for a deep neural network doing direct classification, it is hard
for radiologists to further check which regions are suspicious while the adopted
segmentation-for-classification (S4C) [15] sheds light on the abnormality detec-
tion, which is more plausible. In addition, this harnesses voxelwise annotations
as fully supervision into the classification model, so that the entire network can
be better optimized. Different from [15] which did S4C for PDAC only on venous
phase, we incorporate the dilated pancreatic duct information on both arterial
and venous phases for PNETs, which can further improve the sensitivity.
On our dataset, each training case is associated with a segmentation mask
Mn of the same dimension as Xn, among which mn,i ∈ {0, 1, 2, 3} denotes the
annotated categories for the i-th voxel. More specifically, a background voxel is
labelled as 0, and 1 means the voxel is inside the normal pancreas regions, and
2 denotes a voxel inside the tumor regions. We would like to emphasize that
besides normal/abnormal pancreas regions and background voxels, we annotate
voxels inside dilated pancreatic duct regions as 3. This is motivated from the
knowledge of radiologists that a pancreatic duct dilation is a sign of high risk
for pancreatic cancer. If we predict a dilated pancreatic duct present for some
cases where the PNETs are hardly invisible from textures, we can refine our
judgment and would not miss those really hard cases. Note that a pancreas
set includes the normal pancreas set, abnormal pancreas set and the dilated
pancreatic duct set. The segmentation module is a mapping function M = s(X),
which is implemented by an encoder-decoder network mapping from CT scans
with Hounsfield scale values to the categorical sets. The classification module is
a binary function y = c(M) with a set of rules given the segmentation as input
that we will elaborate later. All in all, the whole framework is denoted as:
y = f(X) = c ◦ s(X). (1)
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Fig. 1. The network backbone of our S4C pipeline. We adopt an encoder-decoder
fashion, where the encoder path on the left acts as a feature extractor to learn more and
more compact features while the decoder path on the right decompresses the learned
features gradually to obtain the dense predictions with higher and higher resolutions.
The sum residual connections from the low-level layers are crucial to integrate the pixel-
level features such as edges to the semantically meaningful features of high-level layers
such as patterns or shapes. The two auxiliary losses serve as a deep supervision to reach
a better optimization process, which favors the final segmentation performance [14].
The whole network is optimized with voxelwise softmax cross-entropy loss. The weight
ratio for auxiliary losses #1, #2 and the main loss is 1 : 2 : 5. Best viewed in color.
2.2 Segmentation for Classification (S4C)
Our segmentation backbone is shown in Fig. 1, which adopts the encoder and
decoder [8] fashion for the dense prediction. The residual connections and auxil-
iary losses are the delicate designs aimed at a better and stable optimization [14].
The pooling layers of the encoder path compress the learning process into more
compact feature space, from where the DeConv layers of the decoder path de-
compress them to semantically meaningful features in the fine-scale resolution.
The whole framework takes the voxelwise softmax cross-entropy as the loss func-
tion, which shows stable and supreme performance on both normal pancreas and
cystic pancreas segmentation [14]. The segmentation network takes patches as
input, whose size is set to be 64×64×64, which covers sufficient context and
makes memory for the networks design with powerful representation ability.
During training, we implemented simple yet effective augmentations on patches
input, i.e., rotation (90◦, 180◦, and 270◦) and flip in all three axes (axial, sagit-
tal and coronal), to increase the number of training samples which can alleviate
the limited number of CT cases with annotations. During testing, we adopted
the sliding window way to slide the whole CT volumes with a 20-voxel spatial
stride. The overlapped regions are voted by majority. Based on the segmenta-
tion prediction, we classify each volume to be abnormal or normal. We compute
the maximal connected component Cmax and keep a component which is either
larger than 20% of Cmax or at a distance of less than 27 voxels to Cmax. As for
classification, a volume is predicted as PNETs if as least 40 voxels are predicted
as tumors or 500 voxels are predicted as dilated pancreatic duct. To harness the
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Fig. 2. The classification network designed for the direct binary classification, i.e.,
tumor versus non-tumor, as an ablation study. Best viewed in color.
dual-phase information, we classify a CT case as abnormal given any phase is
predicted as PNETs, which improves the sensitivity at the cost of the specificity.
2.3 Classification Network as Comparison
Since we adopt the Segmentation-for-Classification framework as our pipeline,
it is natural to see how a classification network performs in comparison. There-
fore, we implement a classification network as shown in Fig 2. To compare the
S4C and classification network as fair as possible, we construct the classifica-
tion network by feeding the features maps of segmentation network as input.
This is due to the fact that the classification label is 0/1 per CT case, which
owns much less information than the voxelwise 0/1’s of segmentation labels. To
filter out the large out-of-pancreas regions during training the classification net-
work, an 128-way feature vector is extracted from the Region-of-Interest (RoI)
of pancreas, which is derived from the ground-truth in the training or from the
segmentation prediction with a margin in the testing. The 128-dimension Pool3
feature is chosen rather than the 256-dimension Conv4b feature vectors because
of the better generalization ability we observed during our experiments. Since
the feature map size is different for different size of pancreas RoIs, the batch
size is chosen to be 1, then a GroupNorm [12] is added after each convolution
in the classification to help the learning process. Note that the segmentation of
pancreas is very good, which makes it doable for the RoI as input.
3 Experiment
3.1 Implementation Details
We collected a new dataset with 376 cases in total from potential renal donors,
in which we have 148 normal cases and 228 biopsy-proven PNETs cases, where
each case has both arterial and venous phases available. Four experts in abdom-
inal anatomy voxelwisely annotated the pancreas, tumor regions, and dilated
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pancreatic duct using the Varian Velocity software, and checked by an experi-
enced board-certified abdominal radiologist. For a radiologist expert, an average
normal case took 20 minutes, and an average abnormal case 40 minutes to fin-
ish the voxelwise annotation. To quantitatively analyze our method, we adopt
a same 4-fold cross-validation for S4C and classification network on these 376
cases in both phases. All in all, for a single phase, each training set contains
111 normal and 171 abnormal cases, and each corresponding testing set contains
57 abnormal and 37 normal cases. And the final quantitative performance is
reported on the testing of all cases across 4 folds, by which we take every case
into consideration to fully maximize the utilization of the medical data which
are expensive and time-consuming to obtain. Our framework is implemented on
Pytorch 0.5.0, and the GPU we are running on is the Tesla V100. The base
learning rate is 0.01 and decayed polynomially (the power is 0.9) in a total of
80,000 iterations with a batch size of 16 for the S4C. The base learning rate is
0.001 and decayed polynomially (the power is 0.9) in a total of 20,000 iterations
for the classification network. The weight decay and momentum are set to be
0.0005 and 0.9, separately. The total training time for a S4C model is 2.5 days
while the average testing time for a case is around 10 mins while the training
time for a classification is ≈ 12 mins given the segmentation features as input.
All parameters are verified by the 4-fold cross-validation.
One of our goals is to quantify the segmentation accuracy by the Dice-
Sørensen Coefficient (DSC) between the predicted and the ground-truth tumor
regions Y and Y?, i.e., DSC(Y,Y?) = 2×|Y∩Y?||Y|+|Y?| . Our primary goal is to measure
the abnormality classification by the sensitivity (the percentage of correctly clas-
sified abnormal cases) and the specificity (the percentage of correctly classified
normal cases). In practice, there is always a trade-off between the sensitivity and
specificity. We care much more about the sensitivity than the specificity since the
final goal is to detect PNETs in the early stage for timely medical interventions.
3.2 Performance
From Table 1 that shows single-phase results, considering venous and arterial
phases equally, our method in the venous phase achieves the best results on all
evaluation matrix except for the comparable result with 3D UNet on the venous
normal pancreas segmentation. On the one hand, the pancreas segmentation
can be as high as 87.41% and 84.69% for the normal pancreas and abnormal
pancreas respectively, which demonstrates the effectiveness of our method. On
the other hand, the tumor segmentation performance is promising to be 43.11%,
which outperforms the state-of-the-art segmentation networks, i.e., 3D UNet [3]
and VNet [6]. From the tumor segmentation results, it is a really challenging
segmentation problem considering the various size, shape and locations of tu-
mors. Note that a recent work on the PDAC segmentation achieves a DSC of
56.46± 26.23% [15], which is not as hard as the PNETs which are less common
with even smaller voxel size. As for the abnormality classification task, our single
phase model achieves 82.46% sensitivity at a specificity of 91.89%, which beats
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Venous Label Ours UNet VNet Arterial Label Ours UNet VNet
Fig. 3. The segmentation visualization for the case number 7263. “Ours” method suc-
cessfully detects the PNETs and dilated pancreatic duct regions on both the venous
and the arterial phase, which performs better then “3D UNet” and “VNet”.
Venous CT Label Ours Arterial CT Label Ours
Fig. 4. The segmentation visualization for the case number 7264. The tiny PNETs is
hanging of the pancreas head, where “Ours” method successfully detects the PNETs
regions on the arterial phase while missing the detection on the venous phase.
the second best 3D UNet by 0.88% and 2.70% respectively. To compare the same
model in arterial and venous phases, we find that all three models behave gener-
ally better on the venous phase than the arterial phase. As in Fig. 3, our method
performs better segmentation results for both venous and arterial phases, which
shows the more powerful representation ability of our network backbone.
3.3 Dual-Phase Fusion and Comparison with Classification Network
In the clinical practice, the radiologists generally care much more about the sen-
sitivity than they do about the specificity when it comes to the tumor detection.
In radiology, some tissues are more visible in the venous phase while others are
better to be captured in the arterial phase. Given we have CT scans in both ar-
terial and venous phases available for each case, it is natural to think that we can
combine the detection results from two phases together to take advantage of the
different enhancement patterns when detecting the abnormality from different
phases. We come up with a very straightforward way to combine the detection
results. More specifically, if a model trained on any phase predicts this case to
be abnormal, we regard this case to be abnormal. In this way, we are able to
reduce the missing cases since a PNETs case can only be missed if both two
phases classify the same case to be normal. The quantitative results are given in
Table 2. First, our model beats both 3D UNet and VNet after the fusion as well.
Second, in the trade-off by fuse two phases, we increase the sensitivity by 7.01%
at the cost of the specificity drop by 10.81%, by which we value the fusion when
it comes to the possible critical point of life or death for patients. As in Fig. 4, we
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Phase Method N.Pancreas A.Pancreas Tumor Misses W.Calls Sensitivity Specificity
Venous Ours 87.41% 84.69% 43.11% 40/228 12/148 82.46% 91.89%
Venous 3D UNet 87.70% 83.84% 41.43% 42/228 16/148 81.58% 89.19%
Venous VNet 86.76% 83.90% 40.67% 49/228 20/148 78.51% 86.49%
Arterial Ours 81.78% 83.34% 42.49% 44/228 21/148 80.70% 85.81%
Arterial 3D UNet 82.47% 83.33% 42.58% 44/228 20/148 80.70% 86.49%
Arterial VNet 83.85% 82.79% 39.22% 43/228 31/148 81.14% 79.05%
Table 1. Performance of segmentation and classification on our own dataset in two
different phases. From left to right: normal pancreas cases, abnormal pancreas cases
and tumor segmentation accuracy (DSC, %), the number of missed abnormal cases out
of 228 abnormal cases in total, the number of wrong calls of tumor predictions out of
148 normal cases in total, the corresponding sensitivity and the specificity.
Phase Method Misses W.Calls Sensitivity Specificity
Arterial&Venous S4C (Ours) 24/228 28/148 89.47% 81.08%
Arterial&Venous 3D UNet 26/228 31/148 88.60% 79.05%
Arterial&Venous VNet 28/228 37/148 87.72% 75.00%
Arterial&Venous Classification 24/228 23/148 89.47% 84.46%
Table 2. Performance of abnormality classification on our own dataset by considering
two phases together. From left to right: the number of missed abnormal cases out of
228 abnormal cases in total, the number of wrong calls of tumor predictions out of 148
normal cases in total, the corresponding sensitivity and the specificity.
visualize one case where our method misses the tumor prediction in the venous
phase while detecting the tiny tumors successfully in the arterial phase.
From Table 2, S4C achieves the best in the sensitivity, which verifies the ef-
fectiveness of S4C framework. For the lower specific city of S4C than the classi-
fication network, we conjecture that the classification network is trained directly
with a binary optimization goal and the feature map of segmentation as input
can be favorable to classification network. However, the major drawback of the
classification network is that it is notoriously hard to identify which regions in
the original CT scans contribute to the final abnormality prediction. But, for our
S4C framework, we provide radiologists with the predicted abnormal regions as
a crucial cue for why we reach the decision. The convenience brought to radiol-
ogists for further diagnosis can be valued even with slightly lower specificity.
4 Conclusion
In this work, we propose an overall framework to conduct the early detec-
tion of PNETs, the second common type of pancreatic cancer. We adopt the
Segmentation-for-Classification strategy to make the classification result more
interpretable to radiologists compared with a direct binary classification net-
work. To quantitatively analyze our method, we voxelwisely annotate the largest
PNETs CT dataset to the best of our knowledge. Furthermore, each CT case
Segmentation for Classification of Screening PNETs 9
is collected in both arterial and venous phase, where the voxels of dilated pan-
creatic duct are annotated as well to increase the sensitivity in practice. Our
approach outperforms the state-of-the-arts segmentation algorithms in terms of
the DSC score and is comparable to a binary classification neural network in
terms of sensitivity and specificity. In the future, we would like to integrate the
classification network into the segmentation backbone, which can let these two
tasks benefit from each other by a joint learning manner.
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Global Image Caption The visualization illustration of predicted segmenta-
tion for “Ours”, “3D UNet” and “VNet” under both Venous and Arterial phases,
respectively, where “V” stands for the “Venous” phase and “A” stands for the
“Arterial” phase. The masked blue, red and green regions denote for the nor-
mal pancreas regions, PNETs regions, and dilated pancreatic duct regions. Best
viewed in color.
Image Label Ours UNet VNet
V
A
Fig. 1. The segmentation visualization for the case number 7011. “Ours” method gives
better performance in the venous phase while comparably good in the arterial phase.
Image Label Ours UNet VNet
V
A
Fig. 2. The segmentation visualization for the case number 7328. “Ours” method suc-
cessfully detects the PNETs regions on both the venous and the arterial phase.
Image Label Ours UNet VNet
V
A
Fig. 3. The segmentation visualization for the case number 7349. “Ours” method suc-
cessfully detects the dilated pancreatic duct regions on both the venous and the arterial
phase, which is a high risk sign for the tumors.
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Image Label Ours UNet VNet
V
A
Fig. 4. The segmentation visualization for the case number 7086. This is a very tiny
PNETs, where “Ours” method successfully detects the PNETs regions on the venous
phase while missing the detection on the arterial phase. In comparison, both “3D UNet”
and “VNet” miss the tumor regions on both phases.
Image Label Ours UNet VNet
V
A
Fig. 5. The segmentation visualization for the case number 7207. The tiny PNETs
is hanging of the pancreas tail, where only “Ours” method successfully detects the
PNETs regions on the venous phase while missing the detection on the arterial phase.
Image Label Ours UNet VNet
V
A
Fig. 6. The segmentation visualization for the case number 7179. “Ours” method de-
tects the dilated pancreatic duct regions fairly good on the arterial phase while mis-
taking the duct to be PNETs on the venous phase.
